MedTrace Logo

Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical Cancer

NCT02809352 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 348

Last updated 2016-06-23

No results posted yet for this study

Summary

Cervical cancer is due to a persistent infection with a group of viruses known as high-risk Human Papillomaviruses (hrHPV). Viral DNA can be easily detected in a cervical sample by a procedure called 'HPV testing', which can be used as a relevant screening test. A pilot screening program called START-HPV has been set up in the Ardennes, a French administrative area localized in the North of France, with HPV testing as a primary screening test.This observational study aimed to evaluate hrHPV genotypes repartition in the population who participate in the START-HPV screening program. This study will allow a better knowledge of hrHPV infection epidemiology in a screened population.

Conditions

Interventions

BIOLOGICAL

Human papillomavirus genotyping

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
31 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02809352 on ClinicalTrials.gov